Trident
Device Hips
PDI 04546540073952
General payments
$50,060,396
Research payments
$3,096,198
Through program year 2025, $50,060,396 in general payments and $3,096,198 in research payments were reported against Trident (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,389,768 | 615 |
| 2025 | Research | $587,676 | 28 |
| 2024 | General | $1,650,032 | 1,058 |
| 2024 | Research | $532,390 | 44 |
| 2023 | General | $12,926,549 | 482 |
| 2023 | Research | $544,163 | 50 |
| 2022 | General | $17,912,687 | 814 |
| 2022 | Research | $835,856 | 67 |
| 2021 | General | $16,181,359 | 751 |
| 2021 | Research | $596,113 | 87 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,720 general · 276 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.